For CRC, the higher expression of MAD2L1 has been observed to counteract the repressive impact of miR-515-5p overexpression on the proliferation of colorectal cancer cells, as well as the induction of apoptosis and G1-phase detainment (Ding et al., 2022). The gene discussed is MAD2L1; the disease is colorectal carcinoma.